KRO-16683

QCR-194; AT-7519M; AT7519 Hydrochloride

902135-91-5
98% min.
scale-up (10-1,000 kg)
C17H21Cl2N5O2

KRO-16684

UNII-X1BF92PW9T; AT 7519

844442-38-2
98% min.
scale-up (10-1,000 kg)
C16H17Cl2N5O2

KRO-11580

Quizartinib; AC220,Quizartinib; AC-220,AC220; AC-220

950769-58-1
98% min.
scale-up (10-1,000 kg)
C29H32N6O4S

KRO-16678

AZD 4547; QCR-89

1035270-39-3
98% min.
scale-up (10-1,000 kg)
C26H33N5O3

KRO-09728

BI6727,Volasertib; BI 6727; Volasertib

755038-65-4
98% min.
scale-up (10-1,000 kg)
C34H50N8O3

KRO-02131

Vismodegib; 2-Chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide

879085-55-9
98% min.
scale-up (10-1,000 kg)
C19H14Cl2N2O3S

KRO-01812

CS-1406; LDK378 Ceritinib; 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-ylphenyl)-N4-[2-(isopropylsulfonyl)phenyl]-pyrimidine-2,4-diamine; Ceritinib (LDK378); 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine; LDK 378; 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine; S7083,LDK 378; LDK378||LDK-378; QC-5183

1380575-43-8; 1032900-25-6
98% min.
scale-up (10-1,000 kg)
C28H36ClN5O3S

KRO-14741

QC-9698; CS-1428; 7-methyl-5-(1-([3-(trifluoromethyl)phenyl]acetyl)-2,3-dihydro-1H-indol-5-yI)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; S7307

1337531-36-8
98% min.
scale-up (10-1,000 kg)
C24H20F3N5O

KRO-14519

lee 011

1211441-98-3
98% min.
scale-up (10-1,000 kg)
C23H30N8O

KRO-11705

Palbociclib HCl; 6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one,hydrochloride

827022-32-2
98% min.
scale-up (10-1,000 kg)
C24H30ClN7O2

KRO-16527

4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide,type II anhydrate; 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide; BI2536; (R)-4-((8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide; 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide,type III anhydrate; 4-[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide,type I anhydrate; BI2536,BI 2536

755038-02-9
98% min.
scale-up (10-1,000 kg)
C28H39N7O3

KRO-09792

TRAMETINIB DIMETHYL SULFOXIDE; Trametinib DMSO; UNII-BSB9VJ5TUT; N-[3-[3-cyclopropyl-5-(2-fluoro-4-iodoanilino)-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1-yl]phenyl]acetamide,methylsulfinylmethane; Trametinib DMSO solvate

1187431-43-1
98% min.
scale-up (10-1,000 kg)
C28H29FIN5O5S

KRO-01007

azd-9291

1421373-65-0
98% min.
scale-up (10-1,000 kg)
C28H33N7O2

KRO-15936

Alectinib; Alectinib; 9-ethyl-6,11-dihydro-6,6-dimethyl-8-(4-(4-morpholinyl)-1-piperidinyl)-11-oxo-5h-benzo(b)carbazole-3-carbonitrile; 9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile; AF802; UNII-LIJ4CT1Z3Y

1256580-46-7
98% min.
scale-up (10-1,000 kg)
C30H34N4O2

KRO-11693

1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli; (6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid; S-(+)-1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazol(4,5-c)pyridine-6-carboxylic acid; pd 123,319 di(trifluoroacetate) salt; PD 123,319; (3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLIC ACID; (S)-1-<<4-(dimethylamino)-3-methylphenyl>methyl>-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo<4,5-c>pyridine-6-carboxylic acid; PD 123,319 DITRIFLUOROACETATE

130663-39-7
98% min.
scale-up (10-1,000 kg)
C31H32N4O3

KRO-15187

LY2484595; trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid; 4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid

1186486-62-3
98% min.
scale-up (10-1,000 kg)
C31H36F6N6O2

KRO-14766

(2R)-N''-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide; GM6001 Galardin Ilomastat

142880-36-2
98% min.
scale-up (10-1,000 kg)
C20H28N4O4

KRO-10082

Suvorexant; 5-chloro-2-{(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl}-1,3-benzoxazole; [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone; DORA-analogue; Belsomra®; [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone; [(R)-4-(5-chlorobenzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl](5-methyl-2-[1,2,3]triazol-2-yl-phenyl)methanone; [(R)-4-(5-chlorobenzoxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)methanone

1030377-33-3
98% min.
scale-up (10-1,000 kg)
C23H23ClN6O2

KRO-06951

4-(4-pentylcyclohexyl)benzoic acid

65355-30-8
98% min.
scale-up (10-1,000 kg)
C18H26O2

KRO-26157

4-(trans-4-butylcyclohexyl)phenol

88581-00-4
98% min.
scale-up (10-1,000 kg)
C16H24O